312 related articles for article (PubMed ID: 26339893)
41. Lung membrane diffusing capacity, heart failure, and heart transplantation.
Mettauer B; Lampert E; Charloux A; Zhao QM; Epailly E; Oswald M; Frans A; Piquard F; Lonsdorfer J
Am J Cardiol; 1999 Jan; 83(1):62-7. PubMed ID: 10073787
[TBL] [Abstract][Full Text] [Related]
42. Multidisciplinary-derived clinical score for accurate prediction of long-term mortality in fibrotic lung disease patients.
Liao YW; Chen YM; Liu MC; Wu YC; Hsu CY; Fu PK; Huang WN; Chen YH
Eur J Med Res; 2024 Jan; 29(1):69. PubMed ID: 38245785
[TBL] [Abstract][Full Text] [Related]
43. Diffuse cystic lung diseases: correlation between radiologic and functional status.
Paciocco G; Uslenghi E; Bianchi A; Mazzarella G; Roviaro GC; Vecchi G; Harari S
Chest; 2004 Jan; 125(1):135-42. PubMed ID: 14718432
[TBL] [Abstract][Full Text] [Related]
44. Increase of pulmonary diffusing capacity in systemic sclerosis.
Dujić Z; Eterović D; Tocilj J; Andjelinović D
Br J Rheumatol; 1994 May; 33(5):437-41. PubMed ID: 8173847
[TBL] [Abstract][Full Text] [Related]
45. Development and Assessment of Novel Lung Ultrasound Interpretation Criteria for the Detection of Interstitial Lung Disease in Systemic Sclerosis.
Fairchild R; Chung M; Yang D; Sharpless L; Li S; Chung L
Arthritis Care Res (Hoboken); 2021 Sep; 73(9):1338-1342. PubMed ID: 32475026
[TBL] [Abstract][Full Text] [Related]
46. Effect of arterial oxygen desaturation on six minute walk distance, perceived effort, and perceived breathlessness in patients with airflow limitation.
Mak VH; Bugler JR; Roberts CM; Spiro SG
Thorax; 1993 Jan; 48(1):33-8. PubMed ID: 8434350
[TBL] [Abstract][Full Text] [Related]
47. In-Person Versus Remote 6-Minute Walk and Incremental Shuttle Walk Distances in Advanced Lung Disease.
Wickerson LM; de Paula Ferreira M; Rozenberg D; Mathur S; Singer LG
Respir Care; 2024 Apr; 69(5):557-565. PubMed ID: 38649272
[TBL] [Abstract][Full Text] [Related]
48. Effectiveness of pulmonary rehabilitation in patients with interstitial lung disease of different etiology: a multicenter prospective study.
Tonelli R; Cocconcelli E; Lanini B; Romagnoli I; Florini F; Castaniere I; Andrisani D; Cerri S; Luppi F; Fantini R; Marchioni A; Beghè B; Gigliotti F; Clini EM
BMC Pulm Med; 2017 Oct; 17(1):130. PubMed ID: 29017478
[TBL] [Abstract][Full Text] [Related]
49. Fibrosing alveolitis in systemic sclerosis: indices of lung function in relation to extent of disease on computed tomography.
Wells AU; Hansell DM; Rubens MB; King AD; Cramer D; Black CM; du Bois RM
Arthritis Rheum; 1997 Jul; 40(7):1229-36. PubMed ID: 9214422
[TBL] [Abstract][Full Text] [Related]
50. Measurements of membrane diffusing capacity and pulmonary capillary blood volume in normal subjects and patients with mild emphysema.
Xie C; Rong Z; Li Z; Yan Y; Light RW
Chin Med J (Engl); 1996 Nov; 109(11):840-7. PubMed ID: 9275367
[TBL] [Abstract][Full Text] [Related]
51. The Performance of Pulmonary Function Tests in Predicting Systemic Sclerosis-Interstitial Lung Disease in the European Scleroderma Trial and Research Database.
Lepri G; Bruni C; Tofani L; Moggi-Pignone A; Orlandi M; Tomassetti S; Hughes M; Del Galdo F; Irace R; Distler O; Riccieri V; Allanore Y; Gheorghiu AM; Siegert E; De Vries-Bouwstra J; Hachulla E; Tikly M; Damjanov N; Spertini F; Mouthon L; Hoffmann-Vold AM; Gabrielli A; Guiducci S; Matucci-Cerinic M; Furst D; Bellando-Randone S; Eustar Collaborators
Diagnostics (Basel); 2024 Jan; 14(3):. PubMed ID: 38337811
[TBL] [Abstract][Full Text] [Related]
52. Pulmonary function test results are correlated with 6-minute walk distance, distance-saturation product, and 6-minute walk work in patients with lymphangioleiomyomatosis.
Diesler R; Cottin V; Gallien Y; Turquier S; Traclet J; Ahmad K; Glerant JC
Respir Med Res; 2024 Jun; 85():101071. PubMed ID: 38141576
[TBL] [Abstract][Full Text] [Related]
53. Phenotyping exercise limitation of patients with Interstitial Fibrosing Lung Disease: the importance of exercise hemodynamics.
Panagiotidou E; Βoutou A; Fouka E; Papakosta D; Chatzopoulos E; Sourla E; Markopoulou A; Kioumis I; Stanopoulos I; Pitsiou G
Pulmonology; 2024; 30(2):104-112. PubMed ID: 35568651
[TBL] [Abstract][Full Text] [Related]
54. Ambulatory oxygen in fibrotic lung disease (AmbOx): study protocol for a randomised controlled trial.
Visca D; Tsipouri V; Mori L; Firouzi A; Fleming S; Farquhar M; Leung E; Maher TM; Cullinan P; Hopkinson N; Wells AU; Banya W; Whitty JA; Adamali H; Spencer LG; Sestini P; Renzoni EA
Trials; 2017 Apr; 18(1):201. PubMed ID: 28454553
[TBL] [Abstract][Full Text] [Related]
55. Bronchiectasis in systemic sclerosis. A study using high resolution computed tomography.
Andonopoulos AP; Yarmenitis S; Georgiou P; Bounas A; Vlahanastasi C
Clin Exp Rheumatol; 2001; 19(2):187-90. PubMed ID: 11326482
[TBL] [Abstract][Full Text] [Related]
56. Reference value for the 6-min walking distance in women with systemic sclerosis considering the impact of muscle strength.
de Oliveira Saraiva NA; de Oliveira Farias I; Dos Santos BM; Xavier RS; Lopes AJ
Clin Biomech (Bristol, Avon); 2023 Oct; 109():106094. PubMed ID: 37725867
[TBL] [Abstract][Full Text] [Related]
57. A remote monitoring-enabled home exercise prescription for patients with interstitial lung disease at risk for exercise-induced desaturation.
Child CE; Kelly ML; Sizelove H; Garvin M; Guilliams J; Kim P; Cai HD; Luo S; McQuade KJ; Swenson ER; Wise AT; Lynch YT; Ho LA; Brown MB
Respir Med; 2023 Nov; 218():107397. PubMed ID: 37640274
[TBL] [Abstract][Full Text] [Related]
58. Biphasic lung diffusing capacity: detection of early asbestos induced changes in lung function.
Dujić Z; Tocilj J; Boschi S; Sarić M; Eterović D
Br J Ind Med; 1992 Apr; 49(4):260-7. PubMed ID: 1315153
[TBL] [Abstract][Full Text] [Related]
59. Relationship between impaired pulmonary diffusion and cardiopulmonary exercise capacity after heart transplantation.
Ewert R; Wensel R; Bruch L; Mutze S; Bauer U; Plauth M; Kleber FX
Chest; 2000 Apr; 117(4):968-75. PubMed ID: 10767226
[TBL] [Abstract][Full Text] [Related]
60. Single-breath diffusing capacity of the lung for carbon monoxide: a predictor of PaO2, maximum work rate, and walking distance in patients with emphysema.
Mohsenifar Z; Lee SM; Diaz P; Criner G; Sciurba F; Ginsburg M; Wise RA
Chest; 2003 May; 123(5):1394-400. PubMed ID: 12740253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
